Back to AVTX

Pivotal bioVenture Partners Investment Advisor LLC → AVTX

Pivotal bioVenture Partners Investment Advisor LLC AVTX Position History

Avalo Therapeutics, Inc. • Healthcare

Quarters held
3
Latest value
$6.7M
Q3 2026
Peak value
$8M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$4.4M
Q2 2026$8M
Q3 2026$6.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$6.7M434.0K——
Q2 2026$8M434.0K——
Q1 2026$4.4M295.9K——

Other funds holding AVTX

Other Pivotal bioVenture Partners Investment Advisor LLC positions

PCVX

VAXCYTE INC

$82.9M
PCVX

VAXCYTE INC

$81.1M
PCVX

VAXCYTE INC

$79.8M
PCVX

VAXCYTE INC

$63.3M
OCSAW

OCULIS HOLDING AG

$45.7M
OCSAW

OCULIS HOLDING AG

$44.7M
EVMN

EVOMMUNE INC

$44.3M
ARQT

ARCUTIS BIOTHERAPEUTICS INC

$39.7M